Butorphanol: Uses, Dosage, and Side Effects

Introduction

Butorphanol is a synthetic opioid medication used for the treatment of moderate to severe pain. It acts as a partial agonist at the mu opioid receptor and a full agonist at the kappa opioid receptor, providing analgesic effects. Developed by Bristol-Myers, butorphanol is available as a nasal spray ( Stadol) and injectable formulations for pain management, including post-operative pain, migraine headaches, and labor pain.

Pharmacological Profile

Mechanism of Action

Butorphanol exerts its analgesic effects through its dual mechanism of action as a partial agonist at the mu opioid receptor and a full agonist at the kappa opioid receptor. This unique pharmacological profile contributes to its therapeutic properties and reduced risk of certain opioid-related side effects ^[1] .

Pharmacokinetics

After administration, butorphanol undergoes rapid absorption and distribution. It has a relatively short half-life and is extensively metabolized in the liver, primarily by hydroxylation and N-dealkylation. The drug is mainly excreted in the urine, with a small proportion eliminated in the feces ^[2] .

Therapeutic Uses

Butorphanol is indicated for the management of various types of pain, including:

• Acute pain: Post-operative pain, labor pain, and other acute pain conditions.
• Migraine headaches: Butorphanol nasal spray is used for the treatment of migraine attacks.
• Chronic pain: Butorphanol may be used in the management of chronic pain conditions, such as cancer pain.
• Veterinary use: Butorphanol is also used in veterinary medicine, particularly for the treatment of colic in horses ^[3] .

Forms and Administration

Butorphanol is available in the following forms:

• Nasal spray ( Stadol): Administered intranasally for the treatment of migraine headaches and other acute pain conditions.
• Injectable formulations: Butorphanol can be administered intravenously (IV), intramuscularly (IM), or subcutaneously (SC) for pain management.

The recommended dosage of butorphanol varies depending on the route of administration, indication, and individual patient factors. It is essential to follow the prescribing information and adjust the dose as needed based on clinical response and tolerability.

Interactions

Butorphanol may interact with other medications, leading to potential adverse effects or altered drug efficacy. Some notable interactions include:

• CNS depressants: Concomitant use of butorphanol with other CNS depressants, such as benzodiazepines or alcohol, can potentiate respiratory depression and sedation.
• Opioid antagonists: Medications like naloxone or naltrexone may reduce the analgesic effects of butorphanol.
• CYP3A4 inhibitors: Drugs that inhibit the CYP3A4 enzyme, such as ketoconazole or ritonavir, may increase butorphanol concentrations and the risk of adverse effects.

It is crucial for healthcare professionals to assess potential drug interactions and adjust treatment plans accordingly to ensure patient safety and optimal therapeutic outcomes.

Side Effects and Adverse Reactions

Like other opioid medications, butorphanol can cause various side effects, ranging from mild to severe. Some common side effects include:

• Drowsiness and sedation
• Dizziness and lightheadedness
• Nausea and vomiting
• Constipation
• Headache
• Sweating
• Respiratory depression (in high doses or susceptible individuals)

Rarely, butorphanol may cause more severe adverse reactions, such as allergic reactions, hallucinations, or addiction. Patients should be monitored closely for any signs of adverse effects, and appropriate measures should be taken to manage these reactions ^[4] .

Butorphanol in Special Populations

Special considerations should be made when using butorphanol in certain populations:

• Pregnancy and breastfeeding: Butorphanol should be used with caution in pregnant women, as it may cause neonatal opioid withdrawal syndrome. The drug is also excreted in breast milk and may cause adverse effects in nursing infants.
• Pediatric patients: The safety and efficacy of butorphanol in children have not been well established, and its use in this population should be carefully considered.
• Elderly patients: Older adults may be more sensitive to the effects of butorphanol, and dose adjustments may be necessary to minimize the risk of adverse reactions.

Contraindications and Precautions

Butorphanol is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should also be used with caution in patients with:

• Respiratory depression or underlying respiratory disorders
• Head injuries or increased intracranial pressure
• Liver or kidney impairment
• A history of substance abuse or addiction

Patients should be closely monitored for any signs of respiratory depression, sedation, or other adverse effects, and appropriate precautions should be taken to ensure patient safety.

Regulation and Legal Status

Butorphanol is classified as a Schedule IV controlled substance in the United States, indicating a lower potential for abuse compared to Schedule II and III drugs. However, it still carries the risk of addiction, dependence, and withdrawal when used inappropriately or for prolonged periods. Prescribers should follow appropriate prescribing guidelines and monitor patients for signs of abuse or dependence.

Clinical Studies and Trials

Numerous clinical studies and trials have investigated the efficacy, safety, and tolerability of butorphanol in various patient populations and indications. These studies have demonstrated the effectiveness of butorphanol in managing moderate to severe pain, including post-operative pain, labor pain, and migraine headaches ^[5] .

Butorphanol Formulations

Butorphanol is available in several formulations, including:

• Butorphanol Tartrate Injection : An injectable solution for intravenous, intramuscular, or subcutaneous administration.
• Stadol (brand name): A nasal spray formulation of butorphanol used for the treatment of migraine headaches and other acute pain conditions.

The choice of formulation depends on the specific indication, patient preferences, and the prescriber’s judgment.

Butorphanol vs Other Opioids

Butorphanol differs from other opioids in its unique pharmacological profile as a partial agonist at the mu opioid receptor and a full agonist at the kappa opioid receptor. This dual mechanism of action may provide certain advantages, such as a lower risk of respiratory depression compared to full mu agonists like morphine ^[6] . However, the choice between butorphanol and other opioids should be based on individual patient factors, the specific indication, and the prescriber’s clinical judgment.

Toxicology and Overdose Management

Butorphanol overdose can lead to severe respiratory depression, sedation, and potentially life-threatening complications. Signs and symptoms of butorphanol toxicity include:

• Pinpoint pupils
• Extreme drowsiness or unconsciousness
• Slow or shallow breathing
• Cold, clammy skin
• Low blood pressure and weak pulse

In case of a suspected butorphanol overdose, immediate medical attention is required. Treatment may involve the administration of the opioid antagonist naloxone, respiratory support, and other supportive care measures ^[7] .

Patient Education

Proper patient education is essential to ensure the safe and effective use of butorphanol. Patients should be informed about:

• The proper administration technique and dosage
• Potential side effects and how to manage them
• The risk of addiction, dependence, and withdrawal
• The importance of securely storing the medication and disposing of unused doses properly
• The need to inform their healthcare provider about any other medications they are taking

Patients should also be encouraged to report any adverse reactions or concerns to their healthcare provider promptly.

LiverTox Information

Butorphanol is not commonly associated with liver injury. However, like other opioids, it undergoes extensive hepatic metabolism and may cause dose-dependent liver toxicity in rare cases. Patients with pre-existing liver impairment may require dose adjustments or alternative pain management options ^[8] .

Chemoinformatics

Butorphanol has the molecular formula C ₂₁H ₂₉NO ₂ and a molecular weight of 327.5 g/mol. It is a morphinan-type synthetic opioid with a complex chemical structure that contributes to its unique pharmacological properties. The PubChem Compound ID (CID) for butorphanol is 5361092 ^[9] .